Observational study / 2014
Urinary resveratrol metabolite levels were not linked to mortality, cardiovascular disease, or cancer in older adults.
In the InCHIANTI prospective cohort study of 783 community-dwelling adults aged 65 or older followed for 9 years, 268 participants (34.3%) died. Across quartiles of baseline 24-hour urinary resveratrol metabolites, all-cause mortality rates were 34.4%, 31.6%, 33.5%, and 37.4% (P = .67), with an adjusted hazard ratio of 0.80 (95% CI, 0.54-1.17) comparing the lowest to the highest quartile. Resveratrol levels were not significantly associated with inflammatory markers (CRP, IL-6, IL-1β, TNF), cardiovascular disease, or cancer.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 783 community-dwelling adults aged 65 years or older from 2 Chianti area villages
- What was measured
- All-cause mortality, inflammatory markers, cardiovascular disease, and cancer
THE PAPER
Resveratrol levels and all-cause mortality in older community-dwelling adults.
Semba RD, Ferrucci L, Bartali B, Urpí-Sarda M, Zamora-Ros R, Sun K, Cherubini A, Bandinelli S, Andres-Lacueva C. JAMA Intern Med, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.